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Background: The aim of this study was to evaluate the test-retest reliability and the validity of the self-reported
questionnaire Olerud-Molander Ankle Score (OMAS) in subjects after an ankle fracture.
Methods: When evaluating the test-retest reliability of the OMAS, 42 subjects surgically treated due to an ankle
fracture participated 12 months after injury. OMAS was completed by the patients on two occasions at one to two
weeks’ interval. Concurrent criterion validity was evaluated using the five subscales of the Foot and Ankle Outcome
Score (FAOS) and global self-rating function (GSRF), which is a five-grade Likert scale with the alternatives: “very
good”, “good”, “fair”, “poor”, “very poor”. Forty-six patients participated in the validation against FAOS, and for GSRF
105 patients participated at 6 months and 99 at 12 months. Uni-, bi- and trimalleolar fractures were all included and
both non-rigid and rigid surgical techniques were used. All fractures healed without complications. Before analysis
of the results the five groups according to GSRF were reduced to three: “good”, “fair” and “poor”. Test-retest
reliability was assessed using Spearman’s rank correlation, the intraclass correlation coefficient (ICC), the standard
error of measurement (SEM and SEM%) and the smallest real difference (SRD and SRD%). The Cronbach’s alpha
score and validity versus FAOS was assessed using Spearman’s rank correlation and validity versus GSRF using the
Kruskal-Wallis Test and the Mann–Whitney U-Test as ad hoc analyses.
Results: The test-retest reliability correlation coefficient obtained was rho = 0.95 and ICC = 0.94. The SEM was 4.4
points and SEM% 5.8% and should be interpreted as the smallest change that indicates a real change of clinical
interest for a group of subjects. The SRD was 12 points and SRD% 15.8% and should be interpreted as the smallest
change that indicates a real change of clinical interest for a single subject. The correlation coefficients versus the
five subscales of FAOS ranged from rho = 0.80 to 0.86. There were significant differences between GSRF groups
“good”, “fair” and “poor” (p < 0.001) at both the six-month and the 12-month follow-up. The internal consistency for
the OMAS was 0.76. The effect size between results from 6-month and 12-month follow-up turned out be 0.44 and
should be considered as medium.
Conclusion: The results showed that the test-retest reliability of the Swedish version of OMAS was very high in
subjects after an ankle fracture and the standard error of measurement was low. Furthermore the OMAS was found
to be valid using both the five subscales of FAOS and the GSRF. The OMAS can thus be used as an outcome
measure after an ankle fracture.
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Fractures involving the ankle are increasing [1] and are
one of the most common fractures in the lower extremity
[2,3] with an incidence rate of 101 fractures per 105
person-years [3]. Ankle fractures occur in all ages and du-
ring different types of daily activities [4,5]. The age-
adjusted incidence rate for the two genders has been
reported as equal [4], but in younger ages the incidence
rate is higher among men and at the age of 50 the gender
ratio reverses [2,4]. The number of ankle fractures in the
elderly is increasing [1,6] and in women over 65 years of
age it has been found to be 300 per 105 person-years [7].
Most fractures are surgically treated with open reduction
and internal fixation due to dislocation [8-12]. After sur-
gery the ankle is normally immobilized in a below knee
plaster cast [13-15] or in a brace [16-18] for six to eight
weeks.
Many investigators have evaluated both short- and
long-term results after surgery [16,19-25]. Radiographic
assessments [23,26], ankle mobility [16,22,26-29] and
muscle strength [16,22,29,30] have been studied. It has
however become more common to use patient-reported
scores to evaluate functional results, as has been done
by many authors [16,18,22,28,31]. As suggested by the
International Classification of Functioning, Disability
and Health (ICF), the degree of impairments, disabilities,
participation problems and health related quality of life
should be described from the patient’s perspective [32].
Patient-reported instruments such as questionnaires are
appropriate instruments for this purpose.
Several scores have been developed in order to evalu-
ate function after ankle injuries [26,33-35]. The Karlsson
score [33] is a patient self-reported questionnaire while
the Kaikkonnen score [34] has to be completed by both
patient and clinician as six of the nine items consist of
clinical tests. Both are mainly intended to evaluate func-
tion after ankle ligament injuries and both have been
found to be valid [36]. The Foot and Ankle Outcome
Score (FAOS) is a self-reported questionnaire and was
developed to assess function in a variety of foot and
ankle-related problems (www.koos.nu). FAOS has been
found valid and reliable [35].
The Olerud-Molander Ankle Score (OMAS) is a
disease-specific questionnaire devised for patients with
ankle fractures and has been frequently used to evaluate
subjectively scored function in this patient group
[16,19,22,23,26,29,31,37]. OMAS has been validated
against: Linear Analogue Scale (LAS) assessing subject-
ive evaluation of ankle function on a 15 cm long linear
analogue scale with the ends marked “perfectly normal
ankle” and “totally disabling ankle” (p < 0.01), range of
motion in dorsal extension (p < 0.05), presence of osteo-
arthritis grade II-IV (p < 0.001) and presence of disloca-
tions on radiographs (p < 0.05) after an ankle fracture[26]. It has also been found to discriminate for subjec-
tively experienced ankle instability (p < 0.02) and muscle
strength in the ankle dorsi- and plantar flexors (p < 0.02)
[22]. Wees et al. examined concurrent validity in pa-
tients with acute ankle ligament injuries and compared
the Ankle Function Score (AFS) and the OMAS. The
concurrent validity between the two scores at baseline
and at follow-up was found to be good (rp = 0.82 and
0.70) [38]. Furthermore OMAS has been reported ca-
pable of recording change over time in the short-term
after an acute ankle ligament injury. The day seven effect
size was reported to 1.3 and day 14 to 2.3 [36,39]. No
floor or ceiling effects have been found when evaluating
patients with acute ankle ligament injuries [38]. Al-
though frequently used, few methodological studies re-
garding OMAS have been performed [22,26,38,39] and
to the best of our knowledge no studies have been pub-
lished assessing the reliability of the OMAS instrument
[36], effect size in the long-term or validity using an-
other disease-specific questionnaire or self-rated func-
tion with a graded rating scale in patients with surgically
treated ankle fracture. The aim of this study was there-
fore to evaluate the test-retest reliability and the validity
of the self-reported questionnaire OMAS in subjects
after an ankle fracture.
Methods
Design and participants
This is a test-retest reliability study and a concurrent
validity study of OMAS. All participants were from the
same cohort and were recruited at the University Hos-
pital in Lund, Sweden. This study is a part of an earlier
intervention study [29] which was approved by the Re-
search Ethics Committee at Lund University, Lund,
Sweden. Written informed consent had to be provided
for participation in the study.
Test-retest reliability of OMAS
Participants
Forty-two subjects, 23 women and 19 men surgically
treated due to an ankle fracture, participated in the
evaluation of the test-retest reliability. The mean age
was 42 (SD 14), 23 had a unimalleolar fracture and 19
had a bi- or trimalleolar fracture. Both non-rigid and
rigid surgical techniques had been used. Fracture types
and surgical techniques that were used have been des-
cribed in detail elsewhere [29]. All subjects had been
immobilized non-weight-bearing in a below-knee plaster
cast and the plaster time was mean 43 days (SD 5.5). All
fractures healed without complications.
Test procedure
The test-retest reliability of OMAS was studied 12 months
after injury. The questionnaire was completed on two sepa-
Nilsson et al. BMC Musculoskeletal Disorders 2013, 14:109 Page 3 of 8
http://www.biomedcentral.com/1471-2474/14/109rate occasions. The first time OMAS was filled in at home
by the 42 subjects and then sent by mail to the test leader
(GN). The second time OMAS was filled in at the clinic
when the subjects were called for a physical examination as
part of a follow-up study [29]. The two sessions were
spaced one to two weeks apart. The subjects did not have
access to the first version when the second was filled in.
Validity of OMAS using global self-rated function
Participants
One-hundred-five patients, 63 women and 42 men, par-
ticipated in the validation of the OMAS at 6 months.
The mean age was 44 (SD 14); 65 subjects had a
unimalleolar fracture and 40 had a bi- or trimalleolar. At
12 months, 99 patients, 59 women and 40 men partici-
pated, the mean age was 45 (SD 14) and 64 had a
unimalleolar and 35 bi- or trimalleolar fracture. Surgical
techniques and immobilization routines were the same
as described above.
Test procedure
OMAS and the global self-rated function (GSRF) were
filled in at home six and twelve months after the injury
and then sent by mail to the test leader (GN).
Validity of OMAS using the Foot and Ankle Outcome
Score
Participants
Forty-six patients, 26 women and 20 men, participated in
the validation of OMAS versus the Foot and Ankle Out-
come Score (FAOS). The mean age was 43 (SD 14) and 25
had a unimalleolar fracture and 21 a bi- or trimalleolar.
Surgical techniques and immobilization routines were the
same as described above.
Test procedure
OMAS was filled in 12 months after the injury and sent
by mail to the test leader. FAOS was filled in at the clinic
when the subjects were called for a physical examination
as part of a follow-up study [29].
Outcome measures
OMAS
OMAS is a self-administered patient questionnaire [26].
The scale is an ordinal rating scale from 0 points (totally
impaired function) to 100 points (completely unimpaired
function) and is based on nine different items given diffe-
rent points: pain (0–25), stiffness (0–10), swelling (0–10),
stair climbing (0–10), running (0–5), jumping (0–5),
squatting (0–5), supports (0–10) and work/activity level
(0–20). The different symptoms are stated and have differ-
ent points according to the extent of disability the authors
considered they would lead to [26]. The score is calculated
as the sum of each rated item. The original version of theOMAS was created in Swedish and this version was the
subject of the present study. Some minor changes were
made in the version that was tested in the present study.
In item three, dealing with swelling, the response alterna-
tives in the original version were “none”, “only evenings”
and “constant”. In the version that we tested the alter-
natives were “none”, “after overuse or only during the
evening” and “constant”. In item four, dealing with stair-
climbing, the response alternatives in the original version
were “no problems”, “impaired” and “impossible”. In the
version that we tested the item was changed to “stairs” in-
stead of “stair climbing” and the response alternatives were
“no problems”, “some problems” and “impossible”. These
changes were made with permission from the Swedish de-
veloper, Professor Claes Olerud (16 March 2012).
GSRF
The GSRF is a self-administered ordinal five-grade rating
scale. The patients have to evaluate their present ankle
function using five alternatives: “very good”, “good”,
“fair”, “poor” and “very poor”.
Global self-rated ankle function can be assessed, for
example, by LAS [17,22,26,33] or by a five-grade Likert
scale (excellent, good, fair, poor, and very poor).
FAOS
FAOS is also a self-administered patient questionnaire
and consists of 42 items divided into five subscales: pain
(9 items), other symptoms (7 items), function in daily liv-
ing (ADL) (17 items), function in sport and recreation and
foot (4 items) and ankle-related quality of life (5 items).
Standardized options are given and for each item a five-
point Likert scale is used (no, mild, moderate, severe, ex-
treme). Each item gets a score from 0–4 and each of the
five subscale scores is calculated as the sum of the rated
items included. Raw scores are then transformed to a scale
0 (indicating extreme symptoms) to 100 (indicating no
symptoms) (www.koos.nu).
FAOS, developed from the self-reported questionnaire
KOOS (Knee Injury and Osteoarthritis Outcome Score),
has been found to be reliable over time in subjects with
surgically treated ankle ligament injuries [35] and valid
against three subscales of SF-36 (bodily pain, physical
functioning and social functioning) (p < 0.01) in subjects
with different foot and ankle disorders in the Turkish
version of FAOS [40]. Furthermore, it has been found
valid against the patient-reported instrument Achilles
Tendon Total Rupture Score (ATRS) in subjects with a
total achilles tendon rupture. All subscales of FAOS cor-
related well with that instrument (p < 0.01) [41].
Statistics
Statistical analyses were performed using the SPSS soft-
ware version 17.0. As OMAS is an ordinal scale non-
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to analyze the standard error of measure (SEM), the
smallest real difference (SRD) and effect size (ES) also
the mean values and standard deviations a had to be ap-
plied. All correlation coefficients (rho) were calculated
using Spearman’s rank correlation, with a coefficient
level of < 0.5 considered as low, 0.5–0.69 as moderate,
0.7–0.89 as high and 0.9–1.0 very high [42]. To analyze
the agreement between the two repeated measurements
at 12-month the intraclass correlation coefficient (ICC)
was applied. To check for systematic error between the
two measurements, the Wilcoxon’s signed rank test was
used. Internal consistency of OMAS was calculated
using Cronbach’s alpha [43]. The standard error of
measure (SEM) was defined by SEM = SD √(1-ICC) and
SEM% by (SEM/mean) × 100 where mean is the mean
for all values from test session 1 and 2. The smallest real
difference (SRD) was defined by SRD = 1.96 × SEM × √2
and the SRD% by SRD/mean × 100 where mean is the
mean for all values from test session 1 and 2. An ‘error
band’ around the mean difference of the two measure-
ments, d, was defined by 95% SRD = d ± SRD [44]. Effect
size of OMAS between six-month and twelve-month
follow-up was calculated as (mean value of measurement
2 – mean value of measurement 1)/SD of measurement
1 [45]. Significance was considered at the alpha level of
p < 0.05. Before the statistical analysis of the validity of
OMAS versus the five-grade rating scale, the subjects
were reduced to three groups. Those who had answered
“very good” and “good” formed one group (Group 1),
“fair” formed one group (Group 2) and those who had
answered “poor” and “very poor” formed one group
(Group 3). When comparing the results between the
three groups the Kruskal Wallis test was used and as ad
hoc between each group the Mann–Whitney U-test was
applied.
Results
Test-retest reliability and internal consistency
No significant differences were found between the two
measurements of OMAS (p = 0.14) and the correlation
(rho = 0.95) and agreement (ICC = 0.94) were both very
high (Table 1). The standard error of measurement
(SEM) which represents the smallest change that indi-
cates a real (clinical) improvement or worsening for a
group of subjects was 4.4 points and SEM% was 5.8%.Table 1 Values of OMAS at first and second measurements an
Variable First measurement Second m
n = 42 n = 42
OMAS median (range) (IQR) 78 (30–100) (26) 80 (35–100
OMAS mean (SD) 75 (19) 77 (18)
¤Wilcoxon sign rank test; rho= spearman correlation coefficient; IQR, Interquartile raThe smallest real difference (SRD) which is the equiva-
lence for a single subject was 12.0 points and the SRD%
was found to be 15.8%. The 95% SRD which represents
the limits for the smallest change for a single subject
ranged from −10.4–13.7. The internal consistency of the
9 items was 0.76 as calculated with Cronbach’s alpha.
Validity of OMAS versus GSRF
There were significant differences in the scoring rates
of OMAS between the three groups of GSRF at both the
six-month (Table 2) and the 12-month follow-up
(Table 3).
Validity of OMAS versus FAOS
The correlation between OMAS and the five subscales
of FAOS was high. All correlation coefficients reached
or exceeded 0.8 (Table 4).
Score distribution and effect size
OMAS varied from 0–100 at six months and 15–100 at
12 months. One person scored 0 at six months. Six per-
sons (5%) scored 100 at six months and 18 persons
(15%) scored 100 at 12 months. Effect size turned out to
be 0.44 calculated as (73.04-62.99)/23.
Discussion
The main results of this study showed that the test-
retest reliability and concurrent validity of the OMAS
were good for patients surgically treated due to an uni-
bi or trimalleolar ankle fracture.
Reliability is an important dimension of any patient-
based outcome measure as it is essential to establish
whether changes observed are due to the intervention
and not to variations related to problems with the out-
come instrument. The larger the random error, the lar-
ger sample size is needed in order to obtain precise
estimates of effects in a trial [45]. There are two aspects
that have to be considered when evaluating reliability:
reproducibility and internal consistency. A correlation
coefficient in a test-retest of a measurement tool should
be at least 0.70 when studying groups of patients and
exceed 0.9 when studying individuals [45,46]. Inter-
nal consistency can be evaluated using Cronbach’s alpha
(0–1) [43]. When items are used to form a scale they
should have internal consistency, which means they
should measure the same thing and be correlated tod correlation between the two measurements
easurement p-value Correlation p-value
correlation
) (30) p = 0.14¤ rho =0.95 p < 0.001
ICC = 0.94 p < 0.001
nge; ICC, intraclass correlation coefficient.
Table 2 OMAS versus global self-rated function six months after injury
Variable Group 1 Group 2 Group 3 p-value
good fair poor
n = 44 n = 36 n = 25
OMAS 6-month median (range) (IQR) 80 (0–100) (19) 60 (20–85) (20) 40 (10–60) (25) p < 0.001¤
¤Kruskal-Wallis Test.
Ad hoc analysis: Group 1 vs Group 2 = p < 0.001 (Mann–Whitney U-test).
Ad hoc analysis: Group 2 vs Group 3 = p < 0.001 (Mann–Whitney U-test).
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0.7–0.8 is recommended [43,45]. Too high levels of
alpha indicate that all items are identical, addressing a
rather narrow aspect of an attribute [43] or there is re-
dundancy among items [45]. Too low levels indicate that
the items included in the scale are not related to each
other [43].
To the best of our knowledge no previous studies have
evaluated the test- retest reliability of OMAS in subjects
surgically treated due to an ankle fracture. Both the
Spearman’s rank correlation coefficient and the ICC bet-
ween the two measurements turned out to be very high
(rho =0.95 and ICC = 0.94), although the circumstances
of the two occasions when the questionnaires were filled
in were not exactly the same; the first version was filled
in at home and the second at the clinic. Cronbach’s
alpha was within the recommended limits (0.76) and
thus the OMAS can be regarded as a reliable measure in
subjects after an ankle fracture.
Even if an ICC value is high it does not mean that a
test is appropriate for clinical use. Before recommending
a test for that issue the measurement errors both for
groups of subjects and for single individuals have to be
analyzed as well. The measurement error of an instru-
ment should be small and sensitive enough to detect real
changes in scored function. In the present study the
SEM and SRD were used which gave the measurement
errors in absolute values. SEM was 4.4 points and SEM%
was 5.8%. These figures are both low and should be
regarded as indicative for true change beyond measure-
ment error and applied as the smallest difference bet-
ween two measurements when evaluating for example
an intervention on group level. The 95% SRD ranged
from −10–13.7 points and indicates that a real clinical
change for a single subject should exceed this range.




OMAS 12-month median (range) (IQR) 85 (50–100) (25)
¤Kruskal-Wallis Test.
Ad hoc analysis: Group 1 vs Group 2 = p < 0.001 (Mann–Whitney U-test).
Ad hoc analysis: Group 2 vs Group 3 = p = 0.021 (Mann–Whitney U-test).like SEM% and may be more easy to use in clinical prac-
tice. The SRD% found was 15.8% and thus if a subject
scores for example 60 points this subject must improve
10 points to indicate a real change. From a clinical point
of view these values seem to be reasonable and confirm
that OMAS can be used to detect real changes in sub-
jects after an ankle fracture.
Criterion validity is the extent to which one measure
is related to other measures or outcomes. This type of
validity can be divided into either concurrent or predic-
tive validity; concurrent validity is when a new tool is to
be compared at the same time with another measure-
ment as gold standard [47]. Often, however, a true gold
standard against which a new measurement can be com-
pared does not exist, and this was the case in our study.
In the present study OMAS was validated using two dif-
ferent instruments, the disease-specific questionnaire
FAOS and the global rating scale, GSRF. FAOS has been
tested for reliability and validity in the Swedish version
[35], the Turkish version [40] and the Iranian version
[48]. The ICC values for test-retest reliability were high
[40,48] and the validity using SF-36 varied between low
and moderate in the Iranian version [48] and between
low and high in the Turkish version [40], but in that
study only three subscales of SF-36 were presented.
SF-36 is an instrument evaluating generic health-related
quality of life, including equal parts of mental health and
physical health, whereas FAOS is a disease-specific in-
strument evaluating functional outcome of the ankle.
Thus not all subscales of SF-36 might be expected to
correlate well with FAOS.
We found that the correlations between OMAS and
the five subscales of FAOS were all high. When looking
at the figures it can be noticed that for the subscale ADL
in FAOS the median value was 99 and the interquartile
range was nine. These figures are more extreme thanter injury
Group 2 Group 3 p-value
fair poor
n = 26 n = 12
60 (30–75) (25) 45 (15–75) (19) < 0.001¤
Table 4 Validity of OMAS versus the five subscales of the foot and ankle outcome score





correlationn = 45 n = 45
80 (30–100) (25) Pain 92 (47–100) (22) 0.86 <0.001
80 (30–100) (25) Symptoms 79 (30–100) (37) 0.81 <0.001
80 (30–100) (25) ADL 99 (54–100) (9) 0.80 <0.001
80 (30–100) (25) Sports 80 (0–100) (45) 0.85 <0.001
80 (30–100) (25) QoL 75 (25–100) (26) 0.81 <0.001
IQR, Interquartile range.
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suggested functions were minor problems for the pa-
tients included in our study. FAOS has been developed
from the self-reported questionnaire KOOS aimed at
evaluating function in subjects with osteoarthritis in the
knee, and the questions are adjusted and relevant to
those patients. We think that not all items might be suit-
able for patients after an ankle fracture especially, not in
the ADL subscale where many items deal with problems
in non-weight-bearing positions such as “bending to
floor”, “putting on socks”, “taking off socks”, “lying in
bed”. It is logical to believe that if patients do not iden-
tify with the problems presented, the total score of those
items would be rated higher. In the validation study of
FAOS the authors came to the same conclusion; only
two of 17 items were considered as “at least of some im-
portance” by the responders [35]. Regarding the subscale
pain, the correlation was high but again the numerical
value for FAOS was higher, and again many of the items
of that subscale of FAOS deal with pain in non-weight
-bearing positions such as “at night while in bed”, “sit-
ting or lying”, “bending foot/ankle fully”, “stretching
foot/ankle fully”. These situations are probably a minor
problem in the studied group with ankle fractures.
Global rating of function was the traditional way of
presenting results after treatment of injuries or diseases
in earlier studies [8,11,49]. As a clinician it is important
to take into account the patient’s overall opinion about
recovery and function after an injury. It should be opti-
mal if the returned responses from a disease-specific in-
strument agree with the patient’s overall rated function
from the same region. OMAS has been shown to corre-
late well in that respect using LAS [26]. In the present
study the evaluation using GSRF agreed well with results
from OMAS. The points from the three groups “good”,
“fair” and “poor” were significantly separated at both the
six-month and the 12-month follow-up.
Responsiveness is one dimension of great importance
to determine when evaluating the methodological quality
of a measurement. The responsiveness of an instrument
expresses its capability to detect changes over time or
changes due to intervention. In the present study theresponsiveness was evaluated by calculating the effect size
and was found to be 0.44 which could be considered as
medium [45]. In the study by Rose et al. the effect size
was evaluated in the early stages after an acute ankle liga-
ment injury and was found to range from 1.3 to 2.3 [39].
It is well known that ankle ligament injuries recover
quickly during the first two weeks, thereby the figures bet-
ween that group and the group that we have focused on
should differ. Between six and 12 months after an ankle
fracture the improvement can be expected to progress
more slowly and by then the effect size found should be
regarded as realistic. There is a lack of knowledge how the
responsiveness of OMAS is in the early phases of the re-
habilitation process after ankle fractures and further stud-
ies regarding this are required.
However, to be able to detect changes over time the
floor and ceiling effects should be considered as well,
which means the number of patients reporting the low-
est score at baseline should be limited in order to be
able to observe deterioration. In the same way ceiling ef-
fect occurs when a patient reports excellent function
and receives the best possible score. Questionnaires with
good validity are expected to have fewer categories with
floor or ceiling effects and no more than 15% of the in-
dividuals should score on these levels [40]. In the
present study no floor or ceiling effects regarding
OMAS were found at six months. At 12 months 15%
scored 100, which is within the recommended limits,
and one year after injury it can be expected that some of
the patients have attained normal function.
OMAS is well known and has been used in lots of
studies for several years [16,17,19,22,23,26,28,29,37,50].
With relatively few items it can be easily completed and
the items included are all relevant to normal activities of
daily life. The score is simple for the researcher to use as
the raw score is summed up without any further calcula-
tion. The different symptoms are given and have diffe-
rent points according to the extent of disability the
authors considered they would lead to [26]. It seems as
if these differences are reasonable, as OMAS and self-
reported global function using both LAS [26] and GSRF
in the present study have shown good correlations. Pain
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that is highest weighted. It seems relevant as the foot
and ankle take weight during every step all day long and
pain in these situations should be strongly disabling. In
two of our earlier studies we found that one year after
the injury more than half of the patients still experienced
pain while walking [22,31].
Ankle fractures surgically treated normally need sta-
bilization of the ankle mortise using either staples or a
screw [8,9,11] and immobilization for six to eight weeks
after surgery in a plaster cast or in an orthosis [51]. These
treatments influence the mobility of the ankle. The sur-
gery technique might diminish the flexibility in the mor-
tise and perhaps also the range of motion in dorsiflexion
in the ankle joint. Maximum of dorsiflexion is needed du-
ring many activities of daily living such as climbing on a
stool, rising from a chair, walking downstairs, walking up-
hill, rising from floor etc. Problems in those situations re-
mind the patient of the injury and would thus be reflected
in the score. Many authors have reported that patients still
complained about stiffness in the ankle one year after the
injury [16,17,22,31].
Swelling has been frequently reported in the studied
patient group [15,17,22,31]. Swelling probably also af-
fects the experience of stiffness and pain. Both stiffness
and swelling are graded relatively high in the scoring
scales, which seems relevant. Running and jumping are
weighted lower. Ankle fracture occurs in all ages but in-
creases with higher age [1,6], particularly in women [7].
Most ankle fractures happen to persons when stumbling
or slipping in everyday life rather than to athletes [4]. It
is thus likely that these functions have less influence in
the main group of injured persons, which might be the
reason why these items were weighted lower by the au-
thors [26]. However, in younger age groups these func-
tions are probably more important to regain, and then
the weighting could be discussed. Furthermore, impedi-
ments or inabilities in return to work or to earlier acti-
vities of daily life might have a great impact on a
person’s life. This item is weighted high, which seems to
be correct.
Despite having relatively few items, the OMAS in-
cludes all dimensions of ICF recommended by the
WHO [32]. Pain, stiffness and swelling belong to the do-
main Body function; stair-climbing, jumping, running
and squatting to the domain Activity; and work/activities
of daily life to the domain Participation. OMAS thus
also fulfills these demands.
Conclusion
In conclusion, the results of this study showed that the
test-retest reliability of the Swedish version of OMAS
was very high in subjects surgically treated after an ankle
fracture and the standard error of measure was low.Furthermore, the concurrent validity using FAOS and
GSRF was high. OMAS can thus be used as an outcome
measure after an ankle fracture.
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